Searching for coeliac disease in patients with non-alcoholic fatty liver disease

Digestive and Liver Disease

Volumn 36, Issue 5, 2004, Pages 333-336

  Bardella, M T ^a   Valenti, L ^a   Pagliari, C ^a   Peracchi, M ^a   Fare M ^b   Fracanzani, A L ^a   Fargion, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

Author keywords

Coeliac disease; Non alcoholic fatty liver disease; Steatohepatitis; Transglutaminase

Indexed keywords

ENDOMYSIUM ANTIBODY; HLA DQ ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; LIVER ENZYME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY SCREENING; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GLUTEN FREE DIET; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; AGE; BLOOD; FATTY LIVER; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGE FACTORS; AUTOANTIBODIES; CELIAC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HLA-DQ ANTIGENS; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; TRANSGLUTAMINASES;

EID: 4544358290     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.01.012     Document Type: Article

References (26)

1. Teli MR, James OFW, Burt AD, Bennet MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-9.
2. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
3. Matteoni CA, Younossi ZM, Gramlich T, Biovparai N, Chang Liu Y, McCollough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
4. Poonawala, Satheesh PN, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-92.
5. Knobler H, Schattner A, Zhornicki T, Malnick SDH, Keter D, Sokolovskaya AN, et al. Fatty liver-an additional and treatable feature of the insulin resistance syndrome. QJM 1999;92:73-9.
6. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCollough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-5.
7. Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis 2003;35:172-8.
8. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor a in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001;48: 206-11.
9. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76.
10. Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, et al. Tumor necrosis factor a promoter polymorphism and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 2002;122:274-80.
11. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180-8.
12. Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology 1995;22:833-6.
13. Grieco A, Miele L, Pignataro G, Pompili M, Rapaccini GL, Gasbarrini G. Is coeliac disease a confounding factor in the diagnosis of NASH? Gut 2001;206:596.
14. Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 2001;46:2347-52.
15. Brunt E. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16.
16. Bardella MT, Trovato C, Cesana BM, Pagliari C, Gebbia C, Peracchi M. Serological markers for celiac disease: is it time to change? Dig Liver Dis 2001;33:426-31.
17. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
18. Volta U, Bellentani S, Bianchi FB, Brandi G, Franceschi L, Miglioli L, et al. High prevalence of celiac disease in Italian general population. Dig Dis Sci 2001;46:1500-5.
19. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niureloni S, et al. Gastrointestinal permeability in celiac disease. Gastroenterology 1997;112:1129-36.
20. Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol 1999;94:691-6.
21. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42.
22. Dieterich W, Laag B, Schopper H, Volta U, Ferguson A, Gillet H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998;115:1317-21.
23. Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 2001;49:506-11.
24. Peracchi M, Trovato C, Longhi M, Gasparin M, Conte D, Tarantino C, et al. Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol 2002;97:2850-4.
25. Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, De Franchis R. High rate of anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 2003;38:50-4.
26. Kaukinen K, Halme L, Collin P, Farkkila M, Maki M, Vehamanen P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002;122:881-8.